Article info
PDFClinical science
A model of the ocular pharmacokinetics involved in the therapy of neovascular age-related macular degeneration with ranibizumab
- Correspondence to Dr Sascha Fauser, Department of Ophthalmology, University Hospital of Cologne, Kerpener Str. 62, Cologne 50924, Germany; sascha.fauser{at}uk-koeln.de
Citation
A model of the ocular pharmacokinetics involved in the therapy of neovascular age-related macular degeneration with ranibizumab
Publication history
- Received February 16, 2015
- Revised March 23, 2015
- Accepted April 22, 2015
- First published May 8, 2015.
Online issue publication
February 27, 2018
Article Versions
- Previous version (11 April 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/